Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Switzerland Daily Monitor.
Press releases published on April 2, 2025
XploraDEX Is Quietly Becoming the Biggest DeFi Opportunity on The XRP Blockchain — Join $XPL Presale
GlobeNewswire
·
April 2, 2025
ZURICH, Switzerland, April 02, 2025 (GLOBE NEWSWIRE) -- XRP Ledger, an ecosystem long admired for its speed, scalability, and utility, one glaring gap has remained: a truly intelligent, AI-enhanced decentralized exchange. That’s exactly what XploraDEX is …
ELEVATE Pre-Launch event in Zurich: Night of Innovation and Networking for Entrepreneurs from all walks of life
EIN Presswire
·
April 2, 2025
Exclusive networking event in Zurich unites top investors, entrepreneurs …
Emerald Portfolio Company P97 Acquired by PDI Technologies
GlobeNewswire
·
April 2, 2025
ZURICH, April 02, 2025 (GLOBE NEWSWIRE) -- Cleantech venture capital pioneer Emerald Technology Ventures has announced that portfolio company P97 Networks has been acquired by PDI Technologies. P97 is a leading provider of mobile commerce and digital …
WISeKey, OISTE Foundation, Abraham House (AbrahamID.Com), and GFLI Announce Major Milestone in Landmark Global Initiative to Deliver Digital Identity to Over One Billion People
GlobeNewswire
·
April 2, 2025
WISeKey, OISTE Foundation, Abraham House (AbrahamID.Com), and GFLI Announce Major Milestone in Landmark Global Initiative to Deliver Digital Identity to Over One Billion People New York | April 2, 2025 – WISeKey International Holding (“WISeKey” or the “ …
XS.com se distingue en tant que sponsor Elite de l'iFX Expo Mexico
EIN Presswire
·
April 2, 2025
FRANCE, April 2, 2025 /Business News/ -- XS.com, le prestigieux fournisseur mondial de fintech multi-actifs et de services financiers, est fier d'annoncer son rôle de sponsor élite pour le prochain iFX EXPO Mexico, prévu du 9 au 10 avril 2025 au …
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
GlobeNewswire
·
April 2, 2025
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein (a-syn) antibody levels on average over 20-fold …
XRP Whales and Traders Are Racing to Join XploraDEX $XPL Presale - XploraDEX Could Be XRP’s 2025 Smartest DeFi Play
GlobeNewswire
·
April 2, 2025
ZURICH, Switzerland, April 02, 2025 (GLOBE NEWSWIRE) -- The race is on, the crypto community turns its attention toward the XRP Ledger, one name is dominating the conversation: XploraDEX. With its native token $XPL Now on Presale, traders and investors are …
Helsinn Group submits a new formulation of AKYNZEO® to the European Medicines Agency (EMA)
GlobeNewswire
·
April 2, 2025
Lugano, Switzerland – April 2, 2025 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of nearly fifty years of commercial execution and a strong focus in supportive care, oncology and dermato-oncology, today announced the …